Conversely, the 2024-25 Knicks tend to disappoint against inferior teams. On Saturday, they lost 121-106 to the Utah Jazz, ...

Roche (RHHBY) announced the FDA approval of a label expansion into biliary tract cancer, or BTC, for the Pathway anti-HER2/neu Rabbit ...

Tesla’s Model 3 ranked last in a German reliability study of newer cars for the second year. The report found a high ...

Zanidatamab is a bispecific antibody that binds to 2 non-overlapping extracellular epitopes of the HER2 receptor.

On a Sunday night in November 2014, Beckham made a play that's held up for a decade as one of the greatest receptions in NFL ...

Los Angeles Lakers rookie small forward, Dalton Knecht, is making a very early Rookie of the Year case with his recent performance.

The Food and Drug Administration granted accelerated approval to zanidatamab-hrii, or Ziihera from Jazz Pharmaceuticals (JAZZ), Inc., a ...

Rookie Dalton Knecht is making waves for Lakers, combining sharpshooting with impactful performances to fuel the team's early ...

The new drug, Jazz Pharmaceuticals’ zanidatamab, has won an FDA accelerated approval for adults with previously treated ...

Jazz Pharmaceuticals (JAZZ) stock and Zymeworks (ZYME) stock gain as FDA clears their cancer therapy Ziihera. Read more here.

They began an early season test last night (Wednesday), beginning a five-game road trip by facing the Phoenix Suns.

Jazz Pharmaceuticals plc (NASDAQ ... unresectable or metastatic HER2-positive (IHC 3+) biliary tract cancer (BTC), as detected by an FDA-approved test. This approval is based on compelling data from ...